6 unchanged sentences
For example, if we hold a security that was issued with a fixed interest rate at the then-prevailing rate and the interest rate later rises, we expect that the fair value of our investment will decline.
−Removed: A hypothetical 100 basis point increase in interest rates would have reduced the fair value of our available-for-sale securities at March 31, 2023 by approximately $0.8 million.
+Added: A hypothetical 100 basis point increase in interest rates would have reduced the fair value of our available-for-sale securities at June 30, 2023 by approximately $0.6 million.
The fair values of our Notes are impacted by both the fair value of our common stock and interest rate fluctuations.
−Removed: As of March 31, 2023, the estimated fair value of the 2025 Notes was $926 per $1,000 principal amount.
+Added: As of June 30, 2023, the estimated fair value of the 2025 Notes was $926 per $1,000 principal amount.
See Note 8, Debt , to our condensed consolidated financial statements included herein for further discussion of our Notes, which bear interest at a fixed rate.
−Removed: At March 31, 2023, all $402.5 million of principal remains outstanding on the 2025 Notes and $8.6 million of principal remains outstanding on the Flexion 2024 Notes.
+Added: At June 30, 2023, all $402.5 million of principal remains outstanding on the 2025 Notes and $8.6 million of principal remains outstanding on the Flexion 2024 Notes.
The TLB Term Loan provided for a single-advance term loan in the principal amount of $375.0 million and was scheduled to mature on December 7, 2026.
1 unchanged sentence
Each term loan borrowing which was a term benchmark borrowing bears interest at a variable rate per annum equal to (i) the Adjusted Term SOFR rate (as defined in the TLB Term Loan Credit Agreement) subject to a 0.75% floor plus (ii) 7.00%.
−Removed: We repaid the outstanding principal for TLB Term Loan on March 31, 2023, therefore there were no outstanding borrowings under the TLB Term Loan as of March 31, 2023.
−Removed: A hypothetical 100 basis point increase in interest rates would have increased interest expense during the three months ended March 31, 2023 by approximately $0.7 million.
+Added: We repaid the outstanding principal for TLB Term Loan on March 31, 2023, therefore there were no outstanding borrowings under the TLB Term Loan as of June 30, 2023.
The TLA Term Loan provides for a single-advance term loan in the principal amount of $150.0 million and is scheduled to mature on March 31, 2028.
Each term loan borrowing that is a term benchmark borrowing or daily simple SOFR borrowing bears interest at a rate per annum equal to (i) the Adjusted Term SOFR Rate or Adjusted Daily Simple SOFR (as each is defined in the TLA Credit Agreement), plus (ii) a spread based on our Senior Secured Net Leverage Ratio ranging from 3.00% to 3.75%.
−Removed: As of March 31, 2023, borrowings under the TLA Term Loan consisted entirely of term benchmark borrowings at a rate of 7.97%.
−Removed: As the agreement was entered into on March 31, 2023, a hypothetical 100 basis point increase in interest rates would have resulted in a nominal increase to interest expense for the three months ended March 31, 2023.
+Added: As of June 30, 2023, borrowings under the TLA Term Loan consisted entirely of term benchmark borrowings at a rate of 8.01%.
+Added: A hypothetical 100 basis point increase in interest rates would have increased interest expense for both the three and six months ended June 30, 2023 by approximately $0.4 million.
As a result of the Flexion Acquisition and as discussed in more detail in Note 8, Debt , to our condensed consolidated financial statements included herein, any future conversion rights for the Flexion 2024 Notes are subject to the occurrence of any future events giving rise to such conversion rights under the indenture governing the Flexion 2024 Notes.
4 unchanged sentences
In the event of non-performance or non-payment, there may be a material adverse impact on our financial condition, results of operations or net cash flow.
−Removed: Pacira BioSciences, Inc.
−Removed: | Q1 2023 Form 10-Q | Page 42
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.